# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019448
Filing Date
2021-08-12
Accepted
2021-08-12 09:02:15
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1534844
2 |  | ex31-1.htm | EX-31.1 | 17836
3 |  | ex31-2.htm | EX-31.2 | 18171
4 |  | ex32-1.htm | EX-32.1 | 7702
| Complete submission text file | 0001493152-21-019448.txt |  | 7027289

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | clsn-20210630.xsd | EX-101.SCH | 56522
6 | XBRL CALCULATION FILE | clsn-20210630_cal.xml | EX-101.CAL | 69028
7 | XBRL DEFINITION FILE | clsn-20210630_def.xml | EX-101.DEF | 222626
8 | XBRL LABEL FILE | clsn-20210630_lab.xml | EX-101.LAB | 452677
9 | XBRL PRESENTATION FILE | clsn-20210630_pre.xml | EX-101.PRE | 340713
10 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1107094

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 211165650
SIC: 2834 Pharmaceutical Preparations